Dr. Menda is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 Hawkins Dr
Iowa City, IA 52242Phone+1 319-356-3214Fax+1 319-356-2220
Education & Training
- University of Iowa Hospitals and ClinicsResidency, Nuclear Medicine, 1998 - 2000
- Istanbul University FomClass of 1994
Certifications & Licensure
- IA State Medical License 1998 - 2026
- American Board of Nuclear Medicine Nuclear Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Clinical Trials
- Study to Calculate the Radiation Dosimetry in Subjects With Head and Neck Cancer Start of enrollment: 2005 Oct 01
- F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients Start of enrollment: 2008 Mar 01
- Positron Emission Mammography With Fluorothymidine (FLT) to Evaluate Treatment Response to Chemotherapy in Breast Cancer Start of enrollment: 2009 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 28 citationsLocalization of Unknown Primary Site with 68Ga-DOTATOC PET/CT in Patients with Metastatic Neuroendocrine Tumor.Yusuf Menda, Thomas M. O'Dorisio, James R. Howe, Michael K. Schultz, Joseph S. Dillon
Journal of Nuclear Medicine. 2017-02-02 - 23 citationsSpatial mapping of functional pelvic bone marrow using FLT PET.Sarah McGuire, Yusuf Menda, Laura L. Boles Ponto, B. Gross, M.J. Tennapel
Journal of Applied Clinical Medical Physics. 2014-07-08 - 47 citationsPhase I Trial of 90Y-DOTATOC Therapy in Children and Young Adults with Refractory Solid Tumors That Express Somatostatin ReceptorsYusuf Menda, M. Sue O'Dorisio, Simon C. Kao, Geetika Khanna, Stacy Michael
Journal of Nuclear Medicine. 2010-10-01
Press Mentions
- A Framework for Patient-Centered Pathways of Care for Radiopharmaceutical Therapy (RPT): An ASTRO Consensus DocumentNovember 26th, 2020
- UI Neuroendocrine Tumor Program Earns High European DistinctionMarch 11th, 2019
- UI Neuroendocrine Tumor Program Earns High European DistinctionMarch 11th, 2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: